A Calgary-based biotech company is turning heads on Tuesday after it was announced that a recent study showed its lead drug candidate MB-204 demonstrated a 400% increase in the...

To read the full story on AllPennyStocks.com, click here.

Grafico Azioni Marvel Biosciences (TSXV:MRVL)
Storico
Da Dic 2024 a Gen 2025 Clicca qui per i Grafici di Marvel Biosciences
Grafico Azioni Marvel Biosciences (TSXV:MRVL)
Storico
Da Gen 2024 a Gen 2025 Clicca qui per i Grafici di Marvel Biosciences